EUVIMEDEUVIMED entdecken
Crossref

Novel NIR-II 3,5-Julolidinyl aza-BODIPY for Photothermal Therapy of Gliomas Stem Cells by Brain Stereotactic Injection

Lulu Cao, Zhiqiang Cui, Dongxiang Zhang, Yikun Li, Xiaoyan Gao, Rong Shang, Xin-Dong Jiang, Jianjun Du, Xiaohong Sun

ACS Materials Letters · 07.10.2024 · 6 (10) · 4765-4773

DOI: 10.1021/acsmaterialslett.4c01447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Materials Letters, online erschienen am 20.09.2024. Verfasst von Lulu Cao und 8 weiteren Autor:innen. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Shenyang University of Chemical Technology, China Medical University, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Shenyang University of Chemical Technology
  • China Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Cao, L., Cui, Z., Zhang, D., Li, Y., Gao, X., Shang, R., Jiang, X., Du, J., & Sun, X. (2024). Novel NIR-II 3,5-Julolidinyl aza-BODIPY for Photothermal Therapy of Gliomas Stem Cells by Brain Stereotactic Injection. ACS Materials Letters, 6(10), 4765-4773. https://doi.org/10.1021/acsmaterialslett.4c01447

Vancouver

Cao L, Cui Z, Zhang D, Li Y, Gao X, Shang R, et al. Novel NIR-II 3,5-Julolidinyl aza-BODIPY for Photothermal Therapy of Gliomas Stem Cells by Brain Stereotactic Injection. ACS Materials Letters. 2024;6(10):4765-4773. doi:10.1021/acsmaterialslett.4c01447

BibTeX
@article{Cao2024,
  author = {Cao, Lulu and Cui, Zhiqiang and Zhang, Dongxiang and Li, Yikun and Gao, Xiaoyan and Shang, Rong and Jiang, Xin-Dong and Du, Jianjun and Sun, Xiaohong},
  title = {Novel NIR-II 3,5-Julolidinyl aza-BODIPY for Photothermal Therapy of Gliomas Stem Cells by Brain Stereotactic Injection},
  journal = {ACS Materials Letters},
  year = {2024},
  volume = {6},
  number = {10},
  pages = {4765--4773},
  doi = {10.1021/acsmaterialslett.4c01447}
}
Kostenlos starten →